Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Fosun International

    World Rank (Aug-2026)
    3,592
    Market Cap (Aug-2026)
    5.089 Billion USD
    World Rank (Jan-05-2024)
    2,998
    Market Cap (Jan-05-2024)
    4.840 Billion USD
    World Rank (Jul-30-2023)
    2,560
    Market Cap (Jul-30-2023)
    5.921 Billion USD
    World Rank (Dec-25-2022)
    2,176
    Market Cap (Dec-25-2022)
    6.509 Billion USD
    World Rank (Jan-07-2022)
    2,050
    Market Cap (Jan-07-2022)
    8.95 Billion USD
    Annual Revenue in USD
    24,581 Million USD
    Annual Operating Income in USD
    640 Million USD
    Annual Net Income in USD
    74 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Fosun International is a Multinational Conglomerate company focused on creating world class products and brands improving global sales and marketing and driving operational efficiency. It operates three business lines in health, happiness and wealth, creating high quality products and services for families around the world. The headquarters is in China.
  2. Guangzhou Baiyunshan Pharmaceutical Holdings Company

    World Rank (Aug-2026)
    3,605
    Market Cap (Aug-2026)
    5.058 Billion USD
    World Rank (Jan-05-2024)
    2,437
    Market Cap (Jan-05-2024)
    6.318 Billion USD
    World Rank (Jul-30-2023)
    2,247
    Market Cap (Jul-30-2023)
    6.926 Billion USD
    World Rank (Dec-25-2022)
    2,127
    Market Cap (Dec-25-2022)
    6.687 Billion USD
    World Rank (Jan-07-2022)
    2,231
    Market Cap (Jan-07-2022)
    8.07 Billion USD
    Annual Revenue in USD
    9,921 Million USD
    Annual Operating Income in USD
    637 Million USD
    Annual Net Income in USD
    556 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in China.
  3. Indivior

    World Rank (Aug-2026)
    3,701
    Market Cap (Aug-2026)
    4.867 Billion USD
    World Rank (Jan-05-2024)
    5,511
    Market Cap (Jan-05-2024)
    2.101 Billion USD
    World Rank (Jul-30-2023)
    4,222
    Market Cap (Jul-30-2023)
    3.140 Billion USD
    World Rank (Dec-25-2022)
    3,930
    Market Cap (Dec-25-2022)
    3.174 Billion USD
    World Rank (Jan-07-2022)
    5,892
    Market Cap (Jan-07-2022)
    2.21 Billion USD
    Annual Revenue in USD
    901 Million USD
    Annual Operating Income in USD
    -91 Million USD
    Annual Net Income in USD
    -53 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Indivior is a global pharmaceutical company working to help change patients lives by pioneering life transforming treatment for substance use disorders and other serious mental illnesses. The company annual revenue is 647 million USD and total assets are 1,531 million USD as on 2020. The headquarters is in UK.

  4. ACADIA Pharmaceuticals

    World Rank (Aug-2026)
    3,702
    Market Cap (Aug-2026)
    4.866 Billion USD
    World Rank (Jan-05-2024)
    2,957
    Market Cap (Jan-05-2024)
    4.917 Billion USD
    World Rank (Jul-30-2023)
    3,125
    Market Cap (Jul-30-2023)
    4.723 Billion USD
    World Rank (Dec-25-2022)
    4,658
    Market Cap (Dec-25-2022)
    2.505 Billion USD
    World Rank (Jan-07-2022)
    4,217
    Market Cap (Jan-07-2022)
    3.63 Billion USD
    Annual Revenue in USD
    1,072 Million USD
    Annual Operating Income in USD
    105 Million USD
    Annual Net Income in USD
    391 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Acadia Pharmaceuticals is a Healthcare and Pharmaceutical company. The company is of food and drug administration for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Around 8 million people in the United States are living with dementia and studies suggest that approximately 30% of people with dementia, 2.4 million people, experience dementia-related hallucinations and delusion. The headquarters is in USA.

  5. Beijing Tongrentang Co. Ltd

    World Rank (Aug-2026)
    3,705
    Market Cap (Aug-2026)
    4.850 Billion USD
    World Rank (Jan-05-2024)
    1,594
    Market Cap (Jan-05-2024)
    10.364 Billion USD
    World Rank (Jul-30-2023)
    1,684
    Market Cap (Jul-30-2023)
    9.941 Billion USD
    World Rank (Dec-25-2022)
    1,732
    Market Cap (Dec-25-2022)
    8.610 Billion USD
    World Rank (Jan-07-2022)
    1,753
    Market Cap (Jan-07-2022)
    10.96 Billion USD
    Annual Revenue in USD
    2,154 Million USD
    Annual Operating Income in USD
    392 Million USD
    Annual Net Income in USD
    200 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Beijing Tongrentang Co. Ltd is a Chinese herbal medicine, nutritional supplements as well as packaged herbal teas and soup bases customized and designed company. It brands currently operates over 2500 clinics and stores worldwide and several hospitals in mainland China. The headquarters is in China.
  6. Ajanta Pharma

    World Rank (Aug-2026)
    3,731
    Market Cap (Aug-2026)
    4.795 Billion USD
    World Rank (Jan-05-2024)
    3,979
    Market Cap (Jan-05-2024)
    3.395 Billion USD
    World Rank (Jul-30-2023)
    4,990
    Market Cap (Jul-30-2023)
    2.469 Billion USD
    World Rank (Dec-25-2022)
    5,749
    Market Cap (Dec-25-2022)
    1.835 Billion USD
    World Rank (Jan-07-2022)
    5,263
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    411 Million USD
    Annual Net Income in USD
    89 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The company annual revenue is 28,896 million INR and annual net income is 6,538 million INR as on 2021. The headquarters is in India.
  7. GlaxoSmithKline Pharmaceuticals (India)

    World Rank (Aug-2026)
    3,752
    Market Cap (Aug-2026)
    4.758 Billion USD
    World Rank (Jan-05-2024)
    3,326
    Market Cap (Jan-05-2024)
    4.282 Billion USD
    World Rank (Jul-30-2023)
    4,498
    Market Cap (Jul-30-2023)
    2.873 Billion USD
    World Rank (Dec-25-2022)
    4,390
    Market Cap (Dec-25-2022)
    2.735 Billion USD
    World Rank (Jan-07-2022)
    3,931
    Market Cap (Jan-07-2022)
    3.96 Billion USD
    Annual Revenue in USD
    410 Million USD
    Annual Net Income in USD
    212 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Glaxosmithkline Pharmaceuticals is a Pharmaceutical company with headquarters is in Mumbai, India.

  8. Shanghai Raas Blood Products

    World Rank (Aug-2026)
    3,769
    Market Cap (Aug-2026)
    4.728 Billion USD
    World Rank (Jan-05-2024)
    2,164
    Market Cap (Jan-05-2024)
    7.290 Billion USD
    World Rank (Jul-30-2023)
    2,243
    Market Cap (Jul-30-2023)
    6.950 Billion USD
    World Rank (Dec-25-2022)
    2,507
    Market Cap (Dec-25-2022)
    5.519 Billion USD
    World Rank (Jan-07-2022)
    2,449
    Market Cap (Jan-07-2022)
    7.26 Billion USD
    Annual Revenue in USD
    920 Million USD
    Annual Operating Income in USD
    286 Million USD
    Annual Net Income in USD
    263 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in China.
  9. Hikma Pharmaceuticals

    World Rank (Aug-2026)
    3,813
    Market Cap (Aug-2026)
    4.631 Billion USD
    World Rank (Jan-05-2024)
    2,843
    Market Cap (Jan-05-2024)
    5.182 Billion USD
    World Rank (Jul-30-2023)
    2,549
    Market Cap (Jul-30-2023)
    5.954 Billion USD
    World Rank (Dec-25-2022)
    3,183
    Market Cap (Dec-25-2022)
    4.138 Billion USD
    World Rank (Jan-07-2022)
    2,587
    Market Cap (Jan-07-2022)
    6.71 Billion USD
    Annual Revenue in USD
    3,233 Million USD
    Annual Operating Income in USD
    619 Million USD
    Annual Net Income in USD
    241 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.

    Facts About Company

    HIKMA PHARMACEUTICALS annual revenue was 2,517 million GBP and annual net income was 188 million GBP generated for period year ending Dec-2022.

    HIKMA PHARMACEUTICALS annual revenue was 2,553 million GBP and annual net loss was 421 million GBP generated for period year ending Dec-2021.

    As on 2022, HIKMA PHARMACEUTICALS had 8800 employees.

  10. IPCA Laboratories

    World Rank (Aug-2026)
    3,835
    Market Cap (Aug-2026)
    4.593 Billion USD
    World Rank (Jan-05-2024)
    3,990
    Market Cap (Jan-05-2024)
    3.385 Billion USD
    World Rank (Jul-30-2023)
    4,748
    Market Cap (Jul-30-2023)
    2.641 Billion USD
    World Rank (Dec-25-2022)
    7,124
    Market Cap (Dec-25-2022)
    1.320 Billion USD
    World Rank (Jan-07-2022)
    4,129
    Market Cap (Jan-07-2022)
    3.72 Billion USD
    Annual Revenue in USD
    722 Million USD
    Annual Net Income in USD
    111 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    IPCA Laboratories is a leading Fully Integrated Pharmaceutical company. It has been a crucial healthcare partner in over 120 countries across the 6 continents and manufactures over 350 formulations and 80 APIs for various therapeutic segments. The company annual revenue is 631.2 million USD and 14,066 employees as on 2020. The headquarters is in India.

Share

Ads